KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash from Investing Activities (2016 - 2026)

Staar Surgical (STAA) has disclosed Cash from Investing Activities for 17 consecutive years, with -$19.4 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities changed 0.41% year-over-year to -$19.4 million, compared with a TTM value of $46.3 million through Jan 2026, up 178.25%, and an annual FY2026 reading of $46.3 million, up 178.25% over the prior year.
  • Cash from Investing Activities was -$19.4 million for Q1 2026 at Staar Surgical, down from $5.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $35.4 million in Q1 2025 and bottomed at -$101.8 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$5.9 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Cash from Investing Activities tumbled 3011.79% in 2022, then skyrocketed 491.22% in 2023.
  • Year by year, Cash from Investing Activities stood at -$46.7 million in 2022, then skyrocketed by 147.95% to $22.4 million in 2023, then tumbled by 187.02% to -$19.5 million in 2024, then surged by 127.1% to $5.3 million in 2025, then plummeted by 467.5% to -$19.4 million in 2026.
  • Business Quant data shows Cash from Investing Activities for STAA at -$19.4 million in Q1 2026, $5.3 million in Q3 2025, and $25.1 million in Q2 2025.